Blocking the hydrolytic shedding of MICB may have promoted the secretion of perforin and granzyme B, leading to more NK cell infiltration of the tumor, which correlates with the activation of immune anti-tumor by MICB binding to ligand NKG2D. The gene discussed is KLRK1; the disease is neoplasm.